# |
PMID |
Sentence |
1 |
19552838
|
Serum Chemerin is correlated with insulin level, body fat disposition and lipid metabolism which suggesting that it may play a role in the pathophysiology of obesity and metabolic syndrome.
|
2 |
19720798
|
Furthermore, higher chemerin release is associated with insulin resistance at the level of lipogenesis and insulin-induced antilipolysis in adipocytes.
|
3 |
20375212
|
Chemerin is a new adipokine involved in in vitro adipogenesis and insulin resistance and associates with body mass index (BMI) in vivo.
|
4 |
20002564
|
Chemerin and vaspin are recently described adipocytokines with various suggested functions and potential to modulate inflammatory response and insulin resistance (IR).
|
5 |
20724582
|
Chemerin reduced insulin-stimulated Akt1 phosphorylation and activation of 5'AMP-activated protein kinase (AMPK) in the skeletal muscle, but had no effect on Akt phosphorylation and insulin-stimulated AMPK activation in the liver and gonadal adipose tissue.
|
6 |
20724582
|
Chemerin induces insulin resistance in the skeletal muscle in vivo.
|
7 |
20601896
|
Multiple regression analysis showed that waist circumference, diastolic blood pressure, 2-hour plasma insulin after glucose overload, and HbA1c were independently related factors influencing plasma chemerin levels.
|
8 |
20601896
|
The present work indicates the potential link of chemerin with the pathogenesis of insulin resistance, obesity, and metabolic syndrome.
|
9 |
20424419
|
Chemerin was recently introduced as a novel adipokine playing a crucial role in adipocyte differentiation and insulin signaling.
|
10 |
21668495
|
Omentin-1 and chemerin have been identified as interesting novel adipokines that may modulate insulin action.
|